In vitro study of ethosome penetration in human skin and hypertrophic scar tissue

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 1026-1033

  Zhang, Zhen ^a   Wo, Yan ^a   Zhang, Yixin ^a   Wang, Danru ^a   He, Rong ^b   Chen, Huijin ^a   Cui, Daxiang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

5 Fluorouracil; Confocal laser scanning microscopy; Ethosome; Hypertrophic scar; Transdermal delivery

Indexed keywords

5-FLUOROURACIL; CONFOCAL LASER SCANNING MICROSCOPY; ETHOSOME; HYPERTROPHIC SCAR; TRANSDERMAL DELIVERY;

CONFOCAL MICROSCOPY; TISSUE;

SKIN;

ALCOHOL; DRUG CARRIER; ETHOSOME; FLUOROURACIL; RHODAMINE 6G; UNCLASSIFIED DRUG; WATER;

ARTICLE; CHEMICAL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLUORESCENCE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PHYSICAL CHEMISTRY; SCAR; SKIN; SKIN HYPERTROPHY; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ADULT; CICATRIX, HYPERTROPHIC; FEMALE; FLUOROURACIL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NANOCAPSULES; SKIN ABSORPTION; TISSUE DISTRIBUTION; TRANSPORT VESICLES; YOUNG ADULT;

EID: 84864103254     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.10.006     Document Type: Article

References (34)

1. Kunii T., Hirao T., Kikuch K., Tagami H. Stratum corneum lipid profile and maturation pattern of corneocytes in the outermost layer of fresh scars: the presence of immature corneocytes plays a much more important role in the barrier dysfunction than do changes in intercellular lipids. Br J Dermatol 2003, 149:749-756.
2. Sogabe Y., Akimoto S., Abe M., Ishikawa O., Takagi Y., Imokawa G. Functions of the stratum corneum in systemic sclerosis as distinct from hypertrophic scar and keloid functions. J Dermatol Sci 2002, 29:49-53.
3. Honeywell-Nguyen P.L., Bouwstra J.A. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today 2005, 2:67-74.
4. Sinico C., Fadda A.M. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009, 6:813-825.
5. Maghraby G.M.E., Williams A.C. Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 2009, 6:149-163.
6. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007, 332:1-16.
7. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000, 65:403-418.
8. Paolino D., Lucania G., Mardente D., Alhaique F., Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005, 106:99-110.
9. Dubey V., Mishra D., Jain N.K. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007, 67:398-405.
10. Dubey V., Mishra D., Dutta T., Nahar M., Saraf D.K., Jain N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007, 123:148-154.
11. Fang Y.P., Tsai Y.H., Wu P.C., Huang Y.B. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm 2008, 356:144-152.
12. Dubey V., Mishra D., Nahar M., Jain V., Jain N.K. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomed Nanotechnol Biol Med 2010, 6:590-596.
13. Chen J.G., Feng L.Y., Gao T.W. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model. J Liposome Res 2010, 1-7.
14. Madsen J.T., Vogel S., Johansen J.D., Sørensen J.A., Andersen K.E., Nielsen J.B. Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes. Cutan Ocul Toxicol 2011, 30:38-44.
15. Madsen J.T., Vogel S., Johansen J.D., Andersen K.E. Encapsulating contact allergens in liposomes, ethosomes, and polycaprolactone may affect their sensitizing properties. Cutan Ocul Toxicol 2011, 30:116-123.
16. Madsen J.T., Vogel S., Karlberg A.T., Simonsson C., Johansen J.D., Andersen K.E. Ethosome formulation of contact allergens may enhance patch test reactions in patients. Contact Dermatitis 2010, 63:209-214.
17. Madsen J.T., Vogel S., Karlberg A.T., Simonsson C., Johansen J.D., Andersen K.E. Ethosome formulations of known contact allergens can increase their sensitizing capacity. Acta Derm Venereol 2010, 90:374-378.
18. Hatamipour E., Mehrabi S., Hatamipour M., Ghafarian Shirazi H.R. Effects of combined intralesional 5-Fluorouracil and topical silicone in prevention of keloids: a double blind randomized clinical trial study. Acta Med Iran 2011, 49:127-130.
19. Shridharani S.M., Magarakis M., Manson P.N., Singh N.K., Basdag B., Rosson G.D. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: a review. Ann Plast Surg 2010, 64:355-361.
20. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010, 125:557-568.
21. Darougheh A., Asilian A., Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 2009, 34:219-223.
22. Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999, 25:224-232.
23. Verma D.D., Verma S., Blume G., Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258:141-151.
24. Maghraby G.M.E., Williams A.C., Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 2001, 53:1069-1077.
25. Glavas-Dodov M., Fredro-Kumbaradzi E., Goracinova K., Simonoska M., Calis S., Trajkovic-Jolevska S., et al. The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005, 291:79-86.
26. Zurada J.M., Kriegel D., Davis I.C. Topical treatments for hypertrophic scars. J Am Acad Dermatol 2006, 55:1024-1031.
27. Chung V., Kelley L., Marra D., Jiang S.B. Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study. Dermatol Surg 2006, 32:193-198.
28. Atiyeh B.S. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 2007, 31:468-492.
29. Brissett A.E., Sherris D.A. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg 2001, 17:263-272.
30. Mao X.H., Wo Y., He R., Qian Y.L., Zhang Y.X., Cui D.X. Preparation and characterization of different Sizes of ethosomes encapsulated with 5-fluorouracil and its experimental study of permeability in hypertrophic scar. J Nanosci Nanotechnol 2010, 10:1-6.
31. Bouwstra J.A., Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006, 1758:2080-2095.
32. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 2006, 322:60-66.
33. Touitou E., Godin B., Dayan N., Weiss C., Piliponsky A., Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001, 22:3053-3059.
34. Dayan N., Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21:1879-1885.